An infant with ETV6-NTRK3 fusion-positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition.
Aditi VediKatherine HollandJustin CrossBrinda MuthusamySam BehjatiC Elizabeth HookMatthew Jonathan MurrayPublished in: Pediatric blood & cancer (2020)